Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ClinTec Expands US Management Team | Contract Pharma
Breaking News, Promotions & Moves

ClinTec Expands US Management Team

Appoints Rick Farris as executive VP of NA Operations

ClinTec International has appointed Rick Farris executive vice president of operations for North America, as the organization continues to grow its clinical research capabilities in the U.S.

With almost 30 years experience in the life sciences industry, Mr. Farris joins ClinTec from Novella Clinical, a Quintiles-owned company, where he held the position of vice president in project management for the biopharma and rare disease business unit. He provided client relationship management and project oversight for clinical trials in rare diseases, oncology, haematology, infectious disease, dermatitis, pain management, and gastroenterology.

Previously, he served as chief operating officer at Health Decisions, a U.S.-based contract research organization (CRO) specializing in female reproductive health, rare disease, diagnostic devices, and oncology.
 
“As ClinTec approaches its 20th year of significant organic growth, we are excited about our expansion plans in North America where we have a growing number of new clients,” said Rabinder Buttar, chief executive officer, ClinTec. “Rick will provide executive leadership to our teams and keep in close contact with our clients to ensure that as we continue to maintain our focus on high quality project delivery, remain highly responsive to client needs and provide a high level of customer service.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters